Abstract P1-11-05: Phase 2 Study of Neoadjuvant Treatment with Cellular Redox Modulator NOV-002 in Combination with Doxorubicin and Cyclophosphamide Followed by Docetaxel (AC→T) in Patients with Stage II-III HER-2 (-) Breast Cancer

Journal article

Peer reviewed

A J Montero, C M Diaz, J Slingerland, M Pegram, J Hurley, C F Welsh, E Avisar, P Seo, C L Vogel, E Garrett-Mayer, …

Cancer research (Chicago, Ill.), Vol.70(24 Supplement), pp.P1-P1-11-05

2010-12-15

Metrics

6 Record Views

This output has contributed to the advancement of the following goals:

Source: InCites

Title: Abstract P1-11-05: Phase 2 Study of Neoadjuvant Treatment with Cellular Redox Modulator NOV-002 in Combination with Doxorubicin and Cyclophosphamide Followed by Docetaxel (AC→T) in Patients with Stage II-III HER-2 (-) Breast Cancer
Creators: A J Montero
C M Diaz
J Slingerland
M Pegram
J Hurley
C F Welsh
E Avisar
P Seo
C L Vogel
E Garrett-Mayer
V Hermann
M K Baker
O Silva
L Koniaris
S Rodgers
K Schuhwerk
C J Pazoles
F Moffat
D J Cole
S Gluck
Publication Details: Cancer research (Chicago, Ill.), Vol.70(24 Supplement), pp.P1-P1-11-05
Academic Unit: Miller School of Medicine
Language: English
Resource Type: Journal article
Record Identifier: 991031599376802976